Skip to content
Screener

Charles River Laboratories CRL Interest Income

Interest Income at other companies

Labcorp Holdings logo
Labcorp HoldingsLH
$5.6M+229%
Rapid Micro Biosystems logo
Rapid Micro BiosystemsRPID
$140K-60.1%
Revvity logo
RevvityRVTY
$6.3M-37.5%
IQVIA logo
IQVIAIQV
$7M-30.0%
NeoGenomics logo
NeoGenomicsNEO
$1.21M-46.4%
Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
$207M—

Other financials

Income statement

See full
Revenue$1.0B-2.7%
Gross profit$349.0M-3.5%
Operating income$119.9M+19.7%
Net income-$1.5M-103%
EPS (diluted)-$0.03-103%

Balance sheet

See full
Cash & equivalents$240.6M+30.2%
Total debt$3.0B+8.1%
Total equity$2.8B-15.3%
Total assets$7.5B-0.4%

Cash flow

See full
Operating cash flow$179.7M-12.2%
CapEx$31.1M-11.9%
Free cash flow$148.6M-12.2%

Valuation

See full
Market cap$12.68B+71.7%
Enterprise value$15.48B+54.6%
P/S3.2×+1.3×

Profitability

See full
Gross margin84.7%—
Operating margin13%-2.4pp
Net margin-6%—
FCF margin9.3%-5.1pp

Returns & leverage

See full
Return on equity-7.7%—
Debt / equity1.1×+0.2×
Current ratio1.3×0.0×

Where this comes from

Reported directly by Charles River Laboratories in its filing.

Tagged under the XBRL concept us-gaap:InvestmentIncomeInterest.

The source filing: Charles River Laboratories’s 10-Q, filed August 5, 2026.

Filed
Aug 5, 2026, 9:21 AM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001100682-26-000118
Line itemThree Months Ended / June 27, 2026Three Months Ended / June 28, 2025Six Months Ended / June 27, 2026Six Months Ended / June 28, 2025
Amortization of intangible assets14,58965,38429,934130,648
Operating income119,888100,134239,785174,803
Other income (expense)
Interest income1,0321,0972,0652,501
Interest expense(30,340)(29,967)(57,082)(57,851)
Other (expense) income, net(37,410)154(161,540)(12,057)
Income before income taxes53,17071,41823,228107,396
Provision for income taxes53,93018,72538,79028,825

Item 1. Financial Statements

FAQ

What is Charles River Laboratories's interest income?
Charles River Laboratories (CRL) reported interest income of $1.03M in Q2 2026.
How has Charles River Laboratories's interest income changed year-over-year?
Charles River Laboratories's interest income decreased by 5.9% year-over-year, from $1.1M to $1.03M.
What is the long-term trend for Charles River Laboratories's interest income?
Over 4 years (2021 to 2025), Charles River Laboratories's interest income has grown at a 65.9% compound annual growth rate (CAGR), from $652K to $4.94M.
What does interest income mean?
Income earned from interest-bearing assets including cash deposits, money market funds, treasury securities, corporate bonds, and customer financing receivables.

Ask your AI about Charles River Laboratories's interest income.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude